146 related articles for article (PubMed ID: 1760768)
1. Changes in apatite crystal size in bones of patients with osteogenesis imperfecta.
Vetter U; Eanes ED; Kopp JB; Termine JD; Robey PG
Calcif Tissue Int; 1991 Oct; 49(4):248-50. PubMed ID: 1760768
[TBL] [Abstract][Full Text] [Related]
2. Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta.
Vetter U; Weis MA; Mörike M; Eanes ED; Eyre DR
J Bone Miner Res; 1993 Feb; 8(2):133-7. PubMed ID: 8442432
[TBL] [Abstract][Full Text] [Related]
3. Two bovine models of osteogenesis imperfecta exhibit decreased apatite crystal size.
Fisher LW; Eanes ED; Denholm LJ; Heywood BR; Termine JD
Calcif Tissue Int; 1987 May; 40(5):282-5. PubMed ID: 3107782
[TBL] [Abstract][Full Text] [Related]
4. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
Vetter U; Fisher LW; Mintz KP; Kopp JB; Tuross N; Termine JD; Robey PG
J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
[TBL] [Abstract][Full Text] [Related]
5. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.
Zeitlin L; Rauch F; Plotkin H; Glorieux FH
Pediatrics; 2003 May; 111(5 Pt 1):1030-6. PubMed ID: 12728084
[TBL] [Abstract][Full Text] [Related]
6. Osteogenesis imperfecta: insufficient collagen synthesis in early childhood as evidenced by analysis of compact bone and fibroblast cultures.
Brenner RE; Vetter U; Nerlich A; Wörsdorfer O; Teller WM; Müller PK
Eur J Clin Invest; 1989 Apr; 19(2):159-66. PubMed ID: 2499474
[TBL] [Abstract][Full Text] [Related]
7. Mechanical and mineral properties of osteogenesis imperfecta human bones at the tissue level.
Imbert L; Aurégan JC; Pernelle K; Hoc T
Bone; 2014 Aug; 65():18-24. PubMed ID: 24803077
[TBL] [Abstract][Full Text] [Related]
8. Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
Rico H; Revilla M; Iritia M; Arribas I; Fernando Villa L
Miner Electrolyte Metab; 1991; 17(6):396-8. PubMed ID: 1823391
[TBL] [Abstract][Full Text] [Related]
9. Type V osteogenesis imperfecta: a new form of brittle bone disease.
Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
[TBL] [Abstract][Full Text] [Related]
10. Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta.
Sarathchandra P; Pope FM; Ali SY
Calcif Tissue Int; 1999 Nov; 65(5):390-5. PubMed ID: 10541766
[TBL] [Abstract][Full Text] [Related]
11. Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters.
Edouard T; Husseini A; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2012 Apr; 97(4):1243-9. PubMed ID: 22319032
[TBL] [Abstract][Full Text] [Related]
12. The functional muscle-bone unit in patients with osteogenesis imperfecta type I.
Veilleux LN; Pouliot-Laforte A; Lemay M; Cheung MS; Glorieux FH; Rauch F
Bone; 2015 Oct; 79():52-7. PubMed ID: 26004918
[TBL] [Abstract][Full Text] [Related]
13. Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.
Kirsch E; Krieg T; Nerlich A; Remberger K; Meinecke P; Kunze D; Müller PK
Calcif Tissue Int; 1987 Jul; 41(1):11-7. PubMed ID: 3113698
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.
Paschalis EP; Gamsjaeger S; Fratzl-Zelman N; Roschger P; Masic A; Brozek W; Hassler N; Glorieux FH; Rauch F; Klaushofer K; Fratzl P
J Bone Miner Res; 2016 May; 31(5):1050-9. PubMed ID: 26748579
[TBL] [Abstract][Full Text] [Related]
15. Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.
Fratzl-Zelman N; Schmidt I; Roschger P; Glorieux FH; Klaushofer K; Fratzl P; Rauch F; Wagermaier W
Bone; 2014 Mar; 60():122-8. PubMed ID: 24296239
[TBL] [Abstract][Full Text] [Related]
16. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
[TBL] [Abstract][Full Text] [Related]
18. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.
Rauch F; Plotkin H; Zeitlin L; Glorieux FH
J Bone Miner Res; 2003 Apr; 18(4):610-4. PubMed ID: 12674321
[TBL] [Abstract][Full Text] [Related]
19. Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing.
Bank RA; Tekoppele JM; Janus GJ; Wassen MH; Pruijs HE; Van der Sluijs HA; Sakkers RJ
J Bone Miner Res; 2000 Jul; 15(7):1330-6. PubMed ID: 10893681
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural studies of bones from patients with osteogenesis imperfecta.
Traub W; Arad T; Vetter U; Weiner S
Matrix Biol; 1994 Aug; 14(4):337-45. PubMed ID: 7827757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
